PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations
PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations. The company focuses on restoring the tumor suppressing function of mutated p53 proteins, which are implicated in approximately half of all human cancers.